However, clinical trials targeting the well-known mediators associated with the response to sepsis, such as PAMPs, endotoxins, and inflammatory cytokines (e.g., IL-6, IFN-gamma, TNF, IL-1beta) have shown discrete or no efficient results.2 The gene discussed is IL6; the disease is Sepsis.